RBC Capital Downgrades Merck & Co to Sector Perform, Raises Price Target to $150

Merck & Co., Inc.

Merck & Co., Inc.

MRK

0.00

RBC Capital analyst Trung Huynh downgrades Merck & Co (NYSE: MRK) from Outperform to Sector Perform and raises the price target from $142 to $150.